Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
PP&E Net
Sonoma Pharmaceuticals Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
PP&E Net
$738k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Johnson & Johnson
NYSE:JNJ
|
PP&E Net
$19.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
PP&E Net
$8.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
PP&E Net
$18.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Merck & Co Inc
NYSE:MRK
|
PP&E Net
$23B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
Eli Lilly and Co
NYSE:LLY
|
PP&E Net
$13.6B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
See Also
What is Sonoma Pharmaceuticals Inc's PP&E Net?
PP&E Net
738k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's PP&E Net amounts to 738k USD.
What is Sonoma Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
-3%
Over the last year, the PP&E Net growth was -7%. The average annual PP&E Net growth rates for Sonoma Pharmaceuticals Inc have been -12% over the past three years , -2% over the past five years , and -3% over the past ten years .